Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CLEO Diagnostics Ltd ( (AU:COV) ) has shared an update.
CLEO Diagnostics Ltd has applied for quotation on the ASX of 28,750 new fully paid ordinary shares under its ticker COV, following the exercise or conversion of existing options or other convertible securities. The modest increase in quoted capital reflects routine capital management and will slightly expand the company’s free float, with limited immediate impact on existing shareholders but maintaining the company’s access to equity markets for future funding and growth initiatives.
The most recent analyst rating on (AU:COV) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on CLEO Diagnostics Ltd stock, see the AU:COV Stock Forecast page.
More about CLEO Diagnostics Ltd
Average Trading Volume: 255,151
Technical Sentiment Signal: Buy
Current Market Cap: A$80.95M
For a thorough assessment of COV stock, go to TipRanks’ Stock Analysis page.